Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Frontiers in Molecular Medicine|August 1, 2024
How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?Sabine Rebs, Katrin Streckfuss-BömekeSTAR Protocols|February 2, 2022
A quantitative RT-PCR protocol to adapt and quantify RBM20-dependent exon splicing of targets at the human locusSabine Rebs, Tjark Alexander Buchwald, Katrin Streckfuss-BömekeStem Cell Research|July 17, 2020
Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutationSabine Rebs, Farbod Sedaghat-Hamedani, Elham Kayvanpour, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 15, 2025
Arrhythpy: an automated tool to quantify and classify arrhythmias in Ca2+ transients of iPSC-cardiomyocytesKarim Ajmail, Charlotte Brand, Thomas Borchert, et al.Stem Cell Research|April 18, 2020
Generation of iPSC-lines from two independent Takotsubo syndrome patients with recurrent Takotsubo eventsDaniela Hübscher, Sabine Rebs, Wiebke Maurer, et al.Stem Cell Research|April 7, 2024
Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutationWiebke Maurer, Sabine Rebs, Steffen Köhne, et al.Stem Cell Research|December 23, 2023
Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathiesHanna Eberl, Sabine Rebs, Stefanie Hoppe, et al.Stem Cell Research|February 25, 2021
Generation and cardiac differentiation of an induced pluripotent stem cell line from a patient with arrhythmia-induced cardiomyopathySabine Rebs, Jakob Beier, Loukas Argyriou, et al.Stem Cell Research|October 8, 2024
Generation of a heterozygous Calsequestrin 2 F189L iPSC line (UMGi158-B) by CRISPR/Cas9 genome editing to investigate the cardiac pathophysiology of Takotsubo Syndrome and Catecholaminergic Polymorphic Ventricular TachycardiaGideon Syed Ali, Sabine Rebs, Hanna Eberl, et al.Journal of Molecular and Cellular Cardiology|December 19, 2021
A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cellsGiulia Emanuelli, Anna Zoccarato, Christina M Reumiller, et al.Pageof 3